c-mpl, the thrombopoietin receptor

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• The v-mpl oncogene is derived from the myeloproliferative leukemia virus (MPLV).
• The cellular homolog, c-mpl, encodes a cytokine receptor crucial for megakaryocytic differentiation.
• This receptor is primarily found in the megakaryocytic lineage.

Purpose of the Study:

• To identify and characterize the ligand for the Mpl receptor.
• To investigate the biological activities of the Mpl receptor ligand.
• To understand the role of the Mpl ligand in platelet production.

Main Methods:

• Isolation of cDNAs encoding the Mpl receptor ligand using the Mpl receptor protein.
• Expression and purification of recombinant Mpl ligand.
• In vitro and in vivo assays to determine biological activities.

Main Results:

• cDNAs for the Mpl receptor ligand were successfully isolated from humans, pigs, dogs, and mice.
• The recombinant Mpl ligand demonstrated both thrombopoietin (TPO) and megakaryocyte-colony stimulating factor (MK-CSF) activities.
• These findings suggest a unified role for the Mpl ligand.

Conclusions:

• The Mpl ligand, also known as TPO/MK-CSF, is a key regulator of platelet production.
• This molecule appears to be the primary humoral factor controlling thrombopoiesis.
• The identification of this ligand has significant implications for understanding and treating platelet disorders.